Form 4 for MRVL Marvell Technology
Accepted 2022-04-19 00:00:00 ET · period of report 2022-04-15 · accession 0000899243-22-015117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2022-04-19 | 2022-04-15 | MRVL | MURPHY MATTHEW J | CEO, Pres, Dir | M - OptEx | $0.00 | +367.2K | 705.4K | +109% | $0 |
| DMI | 2022-04-19 | 2022-04-15 | MRVL | MURPHY MATTHEW J | CEO, Pres, Dir | F - Tax | $60.97 | -167.1K | 697.9K | -19% | -$10.19M |
| DI | 2022-04-19 | 2022-04-18 | MRVL | MURPHY MATTHEW J | CEO, Pres, Dir | S - Sale+OE | $60.64 | -30.0K | 501.9K | -6% | -$1.82M |
| DM | 2022-04-19 | 2022-04-15 | MRVL | MURPHY MATTHEW J | CEO, Pres, Dir | M - OptEx | $0.00 | -367.2K | 0 | -100% | $0 |
| D | 2022-04-19 | 2022-04-15 | MRVL | MURPHY MATTHEW J | CEO, Pres, Dir | A - Grant | $0.00 | +73.8K | 73.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-15 | M | A | 14,910 | $0.00 | 704,178 | I By Trust | — | — | (F3) Shares held by Matthew and Laura Murphy as co-trustees of the Matthew and Laura Murphy Family Trust UTD 7/10/2007. |
| 2 | Common | Common Stock | 2022-04-15 | F | D | 152,115 | $60.97 | 689,268 | I By Trust | — | — | (F3) Shares held by Matthew and Laura Murphy as co-trustees of the Matthew and Laura Murphy Family Trust UTD 7/10/2007. |
| 3 | Common | Common Stock | 2022-04-18 | S | D | 30,000 | $60.64 | 501,886 | I By Trust | — | — | (F1) The sale of these shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. (F2) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.16 to $61.22, inclusive. The reporting person undertakes to provide Marvell Technology, Inc. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. (F3) Shares held by Matthew and Laura Murphy as co-trustees of the Matthew and Laura Murphy Family Trust UTD 7/10/2007. |
| 4 | Common | Common Stock | 2022-04-15 | F | D | 3,331 | $60.97 | 702,052 | I By Trust | — | — | (F3) Shares held by Matthew and Laura Murphy as co-trustees of the Matthew and Laura Murphy Family Trust UTD 7/10/2007. |
| 5 | Common | Common Stock | 2022-04-15 | M | A | 333,194 | $0.00 | 841,383 | I By Trust | — | — | (F3) Shares held by Matthew and Laura Murphy as co-trustees of the Matthew and Laura Murphy Family Trust UTD 7/10/2007. |
| 6 | Common | Common Stock | 2022-04-15 | F | D | 5,296 | $60.97 | 508,189 | I By Trust | — | — | (F3) Shares held by Matthew and Laura Murphy as co-trustees of the Matthew and Laura Murphy Family Trust UTD 7/10/2007. |
| 7 | Common | Common Stock | 2022-04-15 | M | A | 11,599 | $0.00 | 513,485 | I By Trust | — | — | (F3) Shares held by Matthew and Laura Murphy as co-trustees of the Matthew and Laura Murphy Family Trust UTD 7/10/2007. |
| 8 | Common | Common Stock | 2022-04-15 | F | D | 6,312 | $60.97 | 697,866 | I By Trust | — | — | (F3) Shares held by Matthew and Laura Murphy as co-trustees of the Matthew and Laura Murphy Family Trust UTD 7/10/2007. |
| 9 | Common | Common Stock | 2022-04-15 | M | A | 7,517 | $0.00 | 705,383 | I By Trust | — | — | (F3) Shares held by Matthew and Laura Murphy as co-trustees of the Matthew and Laura Murphy Family Trust UTD 7/10/2007. |
| 10 | Derivative | Restricted Stock Units | 2022-04-15 | M | D | 7,517 | $0.00 | 60,134 | D | — · — to — | 7,517 Common Stock | (F5) Each RSU represents a contingent right to receive one Marvell common share upon vesting. (F9) The remaining RSUs will vest on 07/15/2022, 10/15/22, 01/15/2023, 04/15/2023, 07/15/2023, 10/15/2023, 01/15/2024 and 04/15/2024. |
| 11 | Derivative | Restricted Stock Units | 2022-04-15 | M | D | 14,910 | $0.00 | 59,643 | D | — · — to — | 14,910 Common Stock | (F5) Each RSU represents a contingent right to receive one Marvell common share upon vesting. (F8) The remaining RSUs will vest on 07/15/2022, 10/15/22, 01/15/2023 and 04/15/2023. |
| 12 | Derivative | Restricted Stock Units | 2022-04-15 | M | D | 333,194 | $0.00 | 0 | D | — · — to — | 333,194 Common Stock | (F5) Each RSU represents a contingent right to receive one Marvell common share upon vesting. (F7) This grant is fully vested. Reflects the number of shares earned in respect of performance based restricted stock units granted on 04/15/2019. The achievement levels of the relative TSR performance metrics applicable to the award and the number of shares earned based on such results were certified on 04/15/2022. |
| 13 | Derivative | Restricted Stock Units | 2022-04-15 | M | D | 11,599 | $0.00 | 0 | D | — · — to — | 11,599 Common Stock | (F5) Each RSU represents a contingent right to receive one Marvell common share upon vesting. (F6) This award fully vested on April 15, 2022. |
| 14 | Derivative | Restricted Stock Units | 2022-04-15 | A | A | 73,807 | $0.00 | 73,807 | D | — · — to — | 73,807 Common Stock | (F5) Each RSU represents a contingent right to receive one Marvell common share upon vesting. (F10) The RSUs will vest in equal quarterly installments over three years, and were granted as part of the annual grant process. |